Ronggao Chen
About
In The Last Decade
Ronggao Chen
17 papers receiving 314 citations
Peers
Comparison fields: 5 of 55
- Oncology 145
- Pulmonary and Respiratory Medicine 132
- Surgery 125
- Molecular Biology 105
- Cancer Research 92
Countries citing papers authored by Ronggao Chen
This map shows the geographic impact of Ronggao Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronggao Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronggao Chen more than expected).
Fields of papers citing papers by Ronggao Chen
This network shows the impact of papers produced by Ronggao Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronggao Chen. The network helps show where Ronggao Chen may publish in the future.
Co-authorship network of co-authors of Ronggao Chen
This figure shows the co-authorship network connecting the top 25 collaborators of Ronggao Chen. A scholar is included among the top collaborators of Ronggao Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronggao Chen. Ronggao Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 0 | |
| 4 | 14 | |
| 5 | 23 | |
| 6 | 7 | |
| 7 | 4 | |
| 8 | 30 | |
| 9 | Y-320, a novel immune-modulator, sensitizes multidrug-resistant tumors to chemotherapy. | 9 |
| 10 | Endoplasmic reticulum stress triggers delanzomib-induced apoptosis in HCC cells through the PERK/eIF2α/ATF4/CHOP pathway. | 19 |
| 11 | 50 | |
| 12 | LY2228820 induces synergistic anti-cancer effects with anti-microtubule chemotherapeutic agents independent of P-glycoprotein in multidrug resistant cancer cells. | 3 |
| 13 | Cabazitaxel, a novel chemotherapeutic alternative for drug-resistant hepatocellular carcinoma. | 17 |
| 14 | 14 | |
| 15 | 11 | |
| 16 | 56 | |
| 17 | 27 | |
| 18 | 1 | |
| 19 | 32 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.